[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors
Given rapid advancements in medical science, it is often challenging for the busy clinician to
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and …
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and …
[HTML][HTML] Statin treatment-induced development of type 2 diabetes: from clinical evidence to mechanistic insights
U Galicia-Garcia, S Jebari, A Larrea-Sebal… - International Journal of …, 2020 - mdpi.com
Statins are the gold-standard treatment for the prevention of primary and secondary
cardiovascular disease, which is the leading cause of mortality worldwide. Despite the safety …
cardiovascular disease, which is the leading cause of mortality worldwide. Despite the safety …
The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
X Hu, Q Liu, X Guo, W Wang, B Yu, B Liang… - Cardiovascular …, 2022 - Springer
Background Previous research has linked elevated low-density lipoprotein cholesterol (LDL-
C) and remnant cholesterol (RC) with diabetes mellitus (DM). The present study aims to …
C) and remnant cholesterol (RC) with diabetes mellitus (DM). The present study aims to …
[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors–2022
HE Bays, A Agarwala, C German, P Satish… - American Journal of …, 2022 - Elsevier
ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding …
about ten cardiovascular disease risk factors–2022" is a summary document regarding …
PCSK9 and atherosclerosis: Looking beyond LDL regulation
Abstract Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) is involved in cholesterol
homeostasis. After binding to the complex low‐density lipoprotein (LDL)‐receptor, PCSK9 …
homeostasis. After binding to the complex low‐density lipoprotein (LDL)‐receptor, PCSK9 …
Triglyceride-rich lipoprotein metabolism: key regulators of their flux
A Gugliucci - Journal of Clinical Medicine, 2023 - mdpi.com
The residual risk for arteriosclerotic cardiovascular disease after optimal statin treatment
may amount to 50% and is the consequence of both immunological and lipid disturbances …
may amount to 50% and is the consequence of both immunological and lipid disturbances …
Using adipose‐derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?
A Mikłosz, BE Nikitiuk, A Chabowski - Obesity Reviews, 2022 - Wiley Online Library
Obesity is a critical risk factor for the development of metabolic diseases, and its prevalence
is increasing worldwide. Stem cell‐based therapies have become a promising tool for …
is increasing worldwide. Stem cell‐based therapies have become a promising tool for …
[HTML][HTML] Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with …
MA Găman, ME Epîngeac, CC Diaconu… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Obesity and diabetes are associated with high levels of oxidative stress. In
Romanian patients with obesity and (or) diabetes, this association has not been sufficiently …
Romanian patients with obesity and (or) diabetes, this association has not been sufficiently …
A randomized, double‐blind placebo‐controlled add‐on trial to assess the efficacy, safety, and anti‐atherogenic effect of Spirulina platensis in patients with …
SR Karizi, F Armanmehr, HG Azadi… - Phytotherapy …, 2023 - Wiley Online Library
The efficacy of spirulina platensis (S. platensis) as an add‐on therapy to metformin and its
effect on atherogenic keys in patients with uncontrolled Type 2 Diabetes Mellitus (T2DM) …
effect on atherogenic keys in patients with uncontrolled Type 2 Diabetes Mellitus (T2DM) …
Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes
Previous studies have reported age and gender disparities in the occurrence and
therapeutic approach of dyslipidemia and (or) coronary heart disease (CHD) in patients with …
therapeutic approach of dyslipidemia and (or) coronary heart disease (CHD) in patients with …